Patents by Inventor Mizuho SHIBATA

Mizuho SHIBATA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AQUEOUS DRUG
    Publication number: 20200237745
    Abstract: An aqueous drug in which the chemical decomposition of the compound represented by formula (1) or of a salt thereof is inhibited, and a method for producing said aqueous drug. An aqueous drug provided with: a solution (liquid A) that contains the compound represented by formula (1) or a salt thereof and that has a pH of 5.3 or less; and a dilution liquid (liquid B) that is mixed with the liquid A in order to prepare a solution to be administered.
    Type: Application
    Filed: March 5, 2020
    Publication date: July 30, 2020
    Applicant: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Takahiro GOTO, Hitoshi KOZUKA, Mizuho SHIBATA
  • Aqueous drug
    Patent number: 10617684
    Abstract: An aqueous drug in which the chemical decomposition of the compound represented by formula (1) or of a salt thereof is inhibited, and a method for producing said aqueous drug. An aqueous drug provided with: a solution (liquid A) that contains the compound represented by formula (1) or a salt thereof and that has a pH of 5.3 or less; and a dilution liquid (liquid B) that is mixed with the liquid A in order to prepare a solution to be administered.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: April 14, 2020
    Assignee: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Takahiro Goto, Hitoshi Kozuka, Mizuho Shibata
  • Aqueous liquid formulation
    Patent number: 10406149
    Abstract: A novel technique with which it is possible to suppress chemical degradation of a compound represented by general formula (1) or a salt thereof in an aqueous liquid formulation containing a compound represented by general formula (1) or a salt thereof. A method for suppressing the generation of a compound represented by general formula (2) or a salt thereof including containing a compound represented by general formula (1) or a salt thereof and a magnesium compound in an aqueous liquid formulation.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: September 10, 2019
    Assignee: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Wataru Minagawa, Hitoshi Kozuka, Mizuho Shibata, Takahiro Goto, Chifuyu Toriumi, Norihiro Kanayama
  • Aqueous drug
    Patent number: 10206917
    Abstract: An aqueous drug that contains the compound represented by formula (1) or a salt thereof and in which the precipitation and the chemical dissolution of the compound of formula (1) or of a salt thereof is inhibited. An aqueous drug containing: the compound represented by formula (1) or a salt thereof; and a magnesium compound. The aqueous drug has a pH of 5.8-6.9. The concentration of the compound represented by formula (1) is 3 mg/mL or more.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: February 19, 2019
    Assignee: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Takahiro Goto, Hitoshi Kozuka, Mizuho Shibata, Wataru Minagawa, Norihiro Kanayama, Chifuyu Toriumi
  • AQUEOUS DRUG
    Publication number: 20180169088
    Abstract: An aqueous drug that contains the compound represented by formula (1) or a salt thereof and in which the precipitation and the chemical dissolution of the compound of formula (1) or of a salt thereof is inhibited. An aqueous drug containing: the compound represented by formula (1) or a salt thereof; and a magnesium compound. The aqueous drug has a pH of 5.8-6.9. The concentration of the compound represented by formula (1) is 3 mg/mL or more.
    Type: Application
    Filed: June 2, 2016
    Publication date: June 21, 2018
    Applicant: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Takahiro GOTO, Hitoshi KOZUKA, Mizuho SHIBATA, Wataru MINAGAWA, Norihiro KANAYAMA, Chifuyu TORIUMI
  • AQUEOUS DRUG
    Publication number: 20180153875
    Abstract: An aqueous drug in which the chemical decomposition of the compound represented by formula (1) or of a salt thereof is inhibited, and a method for producing said aqueous drug. An aqueous drug provided with: a solution (liquid A) that contains the compound represented by formula (1) or a salt thereof and that has a pH of 5.3 or less; and a dilution liquid (liquid B) that is mixed with the liquid A in order to prepare a solution to be administered.
    Type: Application
    Filed: June 2, 2016
    Publication date: June 7, 2018
    Applicant: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Takahiro GOTO, Hitoshi KOZUKA, Mizuho SHIBATA
  • AQUEOUS LIQUID FORMULATION
    Publication number: 20180147199
    Abstract: A novel technique with which it is possible to suppress chemical degradation of a compound represented by general formula (1) or a salt thereof in an aqueous liquid formulation containing a compound represented by general formula (1) or a salt thereof. A method for suppressing the generation of a compound represented by general formula (2) or a salt thereof including containing a compound represented by general formula (1) or a salt thereof and a magnesium compound in an aqueous liquid formulation.
    Type: Application
    Filed: June 2, 2016
    Publication date: May 31, 2018
    Applicant: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Wataru MINAGAWA, Hitoshi KOZUKA, Mizuho SHIBATA, Takahiro GOTO, Chifuyu TORIUMI, Norihiro KANAYAMA